The concept of and new discovery and emerging therapies
like reverse diabetes for the treatment
of diabetes has expanded in recent years. There is a lot of latest research on
diabetes happening and elaborated at IDF diabetes 2016 and the latest includes
some very rare forms of diabetes which are caused by single gene mutations.
They are called "monogenic" forms of diabetes and new research is
opening the door to specific treatments for these patients. With the advanced type1 diabetes treatment various devices e.g. insulin pumps which is
used for the administration of insulin , rapid HbA1c monitoring, insulin pen,
biomarkers, biostator, artificial pancreas and etc. are formed for the treatment.
Number of innovation and treatment are increasing with the increase in research
work by Research and development department in various sectors and
endocrinology is getting treatment with these devices. Continuous Glucose
Monitoring (CGM) is a relatively new technology which has the potential to
assist people living with type 1 or type 2 Diabetes and treated with insulin to
achieve the goal of optimum control of blood glucose. This will remove the